Nestled in the bustling city of Mumbai, Lupin stands tall as a leading player in the pharmaceutical world, blending innovation with global reach. From everyday medicines to cutting-edge treatments, Lupin’s products touch lives across continents, making healthcare more accessible and affordable.
The pharmaceutical industry isn’t just about pills and potions; it’s about improving lives. In India, where healthcare can be a challenge for many, Lupin’s work is crucial. They develop medicines that help people live healthier, happier lives. But their impact isn’t confined to India alone. Lupin’s influence stretches far and wide, reaching people in countries across Asia, Europe, the Americas, and beyond.
This article delves beyond the numbers to explore Lupin’s journey. It’s about understanding the market, recognizing Lupin’s exceptional performance, and considering the bigger picture of global health. Can Lupin achieve its ambitious price target of 10k? It’s not just about the money; it’s about the potential to keep making a positive difference in countless lives worldwide.
About Lupin
Lupin is a pharmaceutical company based in Mumbai, India, known for its innovative medicines. They make a wide range of medications for various health needs, selling them in over 100 countries, including the U.S., India, South Africa, and across Asia, Latin America, Europe, and the Middle East.
They focus on both branded and generic drugs, as well as biotechnology products and APIs. Lupin is particularly strong in areas like cardiovascular, diabetes, asthma, pediatrics, and central nervous system treatments. In the U.S., they’re a major player, ranking as the third-largest generic company by the number of prescriptions.
With 15 manufacturing facilities worldwide and a strong commitment to research and development, Lupin is dedicated to bringing affordable and effective medicines to people everywhere. They’re constantly expanding their portfolio, with recent acquisitions and new launches aimed at addressing various health concerns globally.
How to Purchase Lupin Shares in India?
Below are the trading platforms that you can use to purchase Lupin shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
Lupin Share Price Target 2024 To 2030
Lupin Share Price Target 2024
| When | Maximum Price | Minimum Price |
| July 2024 | 1,814.60 | 1,577.92 |
| August 2024 | 1,887.19 | 1,641.03 |
| September 2024 | 1,962.68 | 1,706.67 |
| October 2024 | 1,924.19 | 1,673.21 |
| November 2024 | 2,001.16 | 1,740.14 |
| December 2024 | 2,021.17 | 1,757.54 |
In 2024, Lupin’s share prices are anticipated to follow a steady upward trajectory. In July, the maximum price is projected to be ₹1,814.60, with a minimum of ₹1,577.92. By August, the maximum is expected to rise to ₹1,887.19, and the minimum to ₹1,641.03. September’s forecast shows the maximum price reaching ₹1,962.68, with a minimum of ₹1,706.67. In October, prices are projected to peak at ₹1,924.19 and dip to ₹1,673.21. November is expected to see the maximum price at ₹2,001.16 and the minimum at ₹1,740.14. By December, Lupin’s share price is anticipated to reach a maximum of ₹2,021.17 and a minimum of ₹1,757.54.
Lupin Share Price Target 2025
| when | Maximum Price | Minimum Price |
| January 2025 | ₹2,068.94 | ₹1,591.49 |
| February 2025 | ₹2,121.99 | ₹1,632.30 |
| March 2025 | ₹2,204.75 | ₹1,695.96 |
| April 2025 | ₹2,161.52 | ₹1,662.71 |
| May 2025 | ₹2,098.56 | ₹1,614.28 |
| June 2025 | ₹2,193.00 | ₹1,686.92 |
| July 2025 | ₹2,150.00 | ₹1,653.84 |
| August 2025 | ₹2,216.49 | ₹1,704.99 |
| September 2025 | ₹2,294.07 | ₹1,764.67 |
| October 2025 | ₹2,353.71 | ₹1,810.55 |
| November 2025 | ₹2,412.56 | ₹1,855.81 |
| December 2025 | ₹2,472.87 | ₹1,902.21 |
In 2025, Lupin’s share prices are expected to continue their upward trajectory, reflecting a positive outlook for investors. The maximum price is projected to rise steadily throughout the year, starting from ₹2,068.94 in January and reaching ₹2,472.87 by December. Similarly, the minimum price is anticipated to follow an ascending trend, starting at ₹1,591.49 in January and concluding at ₹1,902.21 in December. These trends indicate sustained growth and market confidence in Lupin’s performance and potential. Investors can expect the share price to show consistent upward momentum, providing opportunities for favorable returns throughout the year.
Lupin Share Price Target 2026 To 2030
| Year | Maximum Price | Minimum Price |
|---|---|---|
| 2026 | ₹2,596.51 | ₹1,817.56 |
| 2027 | ₹2,856.17 | ₹1,999.32 |
| 2028 | ₹3,998.63 | ₹1,999.32 |
| 2029 | ₹3,462.02 | ₹1,731.01 |
| 2030 | ₹4,500.62 | ₹3,150.44 |
From 2026 to 2030, Lupin’s share price is expected to witness significant growth, indicative of the company’s strong performance and market confidence. The maximum price is projected to increase steadily over the years, starting from ₹2,596.51 in 2026 and reaching ₹4,500.62 in 2030. Similarly, the minimum price is anticipated to rise progressively, starting at ₹1,817.56 in 2026 and concluding at ₹3,150.44 in 2030. These trends suggest a promising outlook for investors, with Lupin’s share price demonstrating consistent growth potential over the specified period.
Lupin’s Financial Condition (Last 5 Years)
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
| Sales + | 15,375 | 15,163 | 16,405 | 16,642 | 20,011 |
| Expenses + | 13,020 | 12,596 | 16,187 | 14,921 | 16,211 |
| Operating Profit | 2,355 | 2,567 | 219 | 1,721 | 3,800 |
| OPM % | 15% | 17% | 1% | 10% | 19% |
| Other Income + | -134 | 138 | 210 | 151 | 131 |
| Interest | 363 | 141 | 143 | 274 | 312 |
| Depreciation | 970 | 887 | 1,659 | 881 | 1,197 |
| Profit before tax | 887 | 1,676 | -1,372 | 716 | 2,422 |
| Tax % | 130% | 27% | 10% | 38% | 20% |
| Net Profit + | -270 | 1,228 | -1,528 | 448 | 1,936 |
| EPS in Rs | -5.95 | 26.81 | -33.62 | 9.45 | 42.01 |
| Dividend Payout % | -101% | 24% | -12% | 42% | 19% |
- Sales: There has been a significant increase in sales from ₹15,375 crore in March 2020 to ₹20,011 crore in March 2024, demonstrating a steady growth trajectory.
- Expenses: Expenses fluctuated over the years, with a notable rise to ₹16,211 crore in March 2024 from ₹13,020 crore in March 2020. This increase is reflective of higher operational costs.
- Operating Profit: Operating profit showed variability, peaking at ₹3,800 crore in March 2024 compared to ₹2,355 crore in March 2020. The Operating Profit Margin (OPM) improved to 19% in March 2024 from 15% in March 2020, indicating better operational efficiency.
- Other Income: Other income has been inconsistent, with the highest recorded in March 2022 at ₹210 crore and the lowest in March 2020 at -₹134 crore.
- Interest: Interest expenses increased from ₹363 crore in March 2020 to ₹312 crore in March 2024, reflecting changes in financing costs.
- Depreciation: Depreciation has been variable, with a high of ₹1,659 crore in March 2022 and a lower amount of ₹881 crore in March 2023.
- Profit Before Tax: Profit before tax improved significantly to ₹2,422 crore in March 2024 from ₹887 crore in March 2020, reflecting stronger profitability despite fluctuations in previous years.
- Tax Rate: The effective tax rate was notably high at 130% in March 2020 but decreased to 20% in March 2024, impacting the net profit significantly.
- Net Profit: Net profit saw substantial improvement to ₹1,936 crore in March 2024, recovering from losses in March 2020 and March 2022.
- EPS (Earnings Per Share): EPS improved to ₹42.01 in March 2024 from -₹5.95 in March 2020, reflecting enhanced profitability and shareholder value.
- Dividend Payout: The dividend payout ratio fluctuated, with a high of 42% in March 2023 and a decrease to 19% in March 2024, demonstrating changes in profit distribution policies.
FAQS
What is Lupin Ltd’s current market capitalization?
Lupin Ltd’s current market capitalization is ₹82,089 Crore.
What was Lupin Ltd’s closing price on July 23rd?
Lupin Ltd’s closing price on July 23rd was ₹1,800.
What is Lupin Ltd’s stock price-to-earnings (P/E) ratio?
Lupin Ltd’s stock price-to-earnings (P/E) ratio is 43.4.
What is the predicted share price target for Lupin Ltd by 2025?
Lupin Ltd’ share prices ranging from a projected high of ₹2,472.87 to an anticipated low of ₹1,591.49.
What is the predicted share price target for Lupin Ltd by 2030?
The expected maximum price prediction for 2030 is ₹4,500.62.
Also Read
- HINDALCO INDUSTRIES LTD SHARE PRICE TARGET 2024 TO 2030: CAN HINDALCO REACH 2000 INR?
- Tata Teleservices (Maharashtra) Limited Share Price Target 2024, 2025 to 2030
- BANDHAN BANK LTD SHARE PRICE TARGET 2024 TO 2030: CAN BANDHAN BANK REACH 3000 INR?
Should one invest in Lupin?
In conclusion, Lupin Ltd’s financial performance showcases a strong upward trajectory, marked by substantial sales growth and improved profitability. With revenue increasing to ₹20,011 crore and net profit rising to ₹1,936 crore by March 2024, the company demonstrates both resilience and effective management. The significant improvement in operating profit and EPS further highlights Lupin’s robust financial health. Its strategic focus on innovation and global expansion underscores a positive outlook for future performance, making Lupin a compelling prospect for investors.
Leave a Reply